The view of consumers PGEU Symposium 17 June 2013 Ilaria Passarani

Slides:



Advertisements
Similar presentations
Chronic Medication Service (CMS). Programme Introduction Pharmaceutical Care Planning - Ray ePharmacy Programme – Dawn, IM & T Workshops – Niall, Michelle,
Advertisements

Mike Keen, CEO, Kent LPC. Why is change needed? NHS England states that: Primary care services face increasingly unsustainable pressures Community pharmacy.
Disease State Management The Pharmacist’s Role
NPS is an independent, non-profit organisation for Quality Use of Medicines, funded by the Australian Government Department of Health and Ageing. Safe.
Drug Utilization Review (DUR)
Protecting patients- now and in the future Linda Matthew Senior Pharmacist National Patient Safety Agency.
Clinical Pharmacy Basma Y. Kentab MSc..
Clinical pharmacy Dr. Mohammed Al-Rekabi Lecture One First Semester.
Presented by Vicki M. Young, PhD October 19,
Pharmacy Services.
1. How can we promote pharmacies and the full service available? Think about: How the NHS works with Local Authorities to enhance the role of community.
Why are we learning this? How scientific knowledge (pharmacology, therapeutics) and clinical skills (measuring blood pressure, glucoses, drug information)
Primary Care Workforce Summit November 29, 2012 Country Springs Hotel, Waukesha Primary Care Workforce Summit Pharmacy Perspective Kate Hartkopf, PharmD.
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
The Value of Medication Therapy Management Services.
Clinical Pharmacy Part 2
Scottish Patient Safety Programme – Pharmacist Engagement Gordon Thomson Arlene Coulson Shadi Botros.
Exclusively serving Indiana families since Population Health Management from the Managed Care Entity Perspective IPHCA Annual Conference 2015.
Introduction.
Strengthening the commitment
Community Pharmacy in 2016 and beyond: A summary of the Pharmacy Voice response Nanette Kerr Chief Executive Officer Company Chemists’ Association A member.
Putting Patients at the Centre of Care What can my Community Pharmacist do for me? Dr Tarlochan Gill Chairman, Kent & Medway Pharmacy Local Professional.
Community Pharmacy in 2016 and beyond: A summary of the Pharmacy Voice response Elizabeth Wade Director of Policy, Pharmacy Voice April 2016 Slide 1 of.
Pharmaceutical Society of Ireland – The Pharmacy Regulator The Role of the Pharmacist in Self Care Telephone: Shrewsbury Rd Fax:
An agency of the European Union Sharing Our Vision? A view from the European Medicines Agency PGEU Symposium, 17 June 2013, Rome Presented by: Guido Rasi.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
GB.DRO f, date of preparation: January 2010 Dartford and Gravesham NHS Trust Pharmacy Services in Hospital.
 Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist to work in concert with the patient and.
Safety in Medicines: Raising the profile with the Royal Pharmaceutical Society Liz Rawlins Communications Officer 9 May 2011.
Rural West Primary Health Care (PHC) Team December 9 – 10, Calgary.
European Community Pharmacy Blueprint A perspective from general practice Professor Tony Avery.
Documentation in Practice Dept. of Clinical Pharmacy.
Darragh O’Loughlin MPSI IPU Secretary General Irish Pharmaceutical Healthcare Association RDS, Dublin: 26 November 2013.
Pharmacy White Paper Building on Strengths Delivering the Future Overview.
Drug Utilization Review & Drug Utilization Evaluation: An Overview
PHARMACEUTICAL GUIDELINES: BASIC PRINCIPLES AND STATUTES.
EU Health Priorities Jurate Svarcaite Secretary General PGEU.
Role of Pharmacist in Quality and Integrated Care
THE HEALTHCARE SUPPORT WORKER
IPHA Switch-on to Self-Care From Primary Care to Self-Care
PHARMACIST : A HEALTH CARE PROFESSIONAL
The Many Careers of Pharmacy
Improving Health Literacy Today….not Tomorrow”
Community Pharmacy: Sharing Our Vision
Prescribing.
Cooperation for Better Regulation
Champlain LHIN Collaboration
Clinical Pharmacy II.
Introduction to Clinical Pharmacy
Professor Colin P. Bradley University College Cork
Integrating Clinical Pharmacy into a wider health economy
CHAPTER 4 Information Management in Pharmacy.
HEALTH PROFESSIONAL ENGAGEMENT PROGRAMME:
Fiona Caplan-Dean Pharmacy Services Development Manager UK
Community Step Up Program
Information for Network Providers
Engaging and Empowering People and Communities
Research for all Sharing good practice in research management
Provider and Member Education in Managed Care Pharmacy
Pharmacy practice experience I
Scotland’s Digital Health and Care Strategy
Medicines Safety Programme
Pharmacy practice and the healthcare system Ola Ali Nassr
Moving Forward Together Programme Overview
EESC Public Hearing 30-Jan-2019
Hospital pharmacy.
PPG Meeting on general practice is changing
Let’s talk medicines safety
SAMPLE ONLY Dominion Health Center: Your Community Partner for Excellent Care (or another defining message) Dominion Health Center is a community health.
Point of Dispensing and Counselling Intervention Enhanced Service: Community Pharmacy (PODIS)
Presentation transcript:

The view of consumers PGEU Symposium 17 June 2013 Ilaria Passarani Senior health policy officer PGEU Symposium 17 June 2013

The information jungle Support Advice The information jungle 10/12/2018

Health care professionals: a trusted source of information and advice Which?, 2010

Consumers’ expectations A trusted source of information and advice Honest and credible Comparative, objective and unbiased information More questions and more answers More active role in the detection of possible interactions Proactive advice A consumer friendly pharmacy

Results of an undercover investigation in the UK 122 pharmacies across the UK 3 scenarios Good practice but also disappointing results Unsatisfactory advices in 43% of visits Better results than Which? last investigation in 2008 but lack of questioning leads to some inadequate advice and potentially serious consequences Which?, June 2013

Interactions SCENARIOS Anticoagulant + Aspirin Contraceptive pill + Hypericum Test-Achats, May 2012

Too nonchalants UFC Que Choisir inquiry 648 pharmacies in 14 French cities on 19-20 January 2012 Scenario: patient with a cold and fatigue asked for a box of acetylsalicylic acid and a box of ibuprofen. 52 % spontaneously warned the consumer about the incompatibility of the two products 11% warned about the incompatibility only in response to a specific question from the consumer 37% didn’t mention anything 14% asked about the consumer medical history

Sales out of control BEUC members mystery shopping for a weight loss medicine (Orlistat) BMI ≥28 kg/m2 , only for adults, not suitable for pregnant and breast feeding women, special care in case of diabetes, use of oral contraceptive, kidney disease, use of other medicines etc. - UK ( May 2009) - Ireland ( September 2009); - Spain ( July 2009) - Belgium (October 2009) - Portugal ( February 2010) - Italy (May 2010) - Austria ( April 2011) Disappointing results: In 70 % of the 86 pharmacies visited in Spain the product was sold to consumers with a BMI between 18 and 24. In 74% of the 103 pharmacies visited in Italy the product was sold to consumers with a BMI < 28. In most cases it was sold without any question on the consumer weight and possible health problems and with no advice on healthy diet/physical activity. In 10 out of 16 pharmacies in Vienna the product was sold to a 15 year old girl with BMI of 19,4 and in 6 of them the product was sold to a breast feeding mother with a BMI of 25,1.

Proactive advice Consumers who bought an OTC received spontaneous advice from the pharmacist: OCU, Test-Achats, Altroconsumo, DECO,2008 Total sample: 4.089 people from 18 to 92 yro

European Community pharmacists’ blueprint ENHANCE MEDICINE SAFETY AND ACCESS TO MEDICINES Further strengthen the medicines supply chain to prevent falsified medicines reaching hands of European patients Work with other stakeholders and governments to prevent medicine shortages; Make more hospital-only medicines available via community pharmacies; Deliver medicines to care homes and the patients’ homes and assist patients of our pharmacies who have complex treatment regimes in managing their medication, by providing pharmacy services such as individual single-dosage systems for our patients in the pharmacy; Have the possibility to dispense prescription only medicines without a medical prescription in emergencies, under strict conditions and in collaboration with physicians; IMPROVE TREATMENT OUTCOMES OF INDIVIDUAL PATIENTS Manage medication while further empowering patients to self-manage their condition; Maximise our patient care interventions through gaining access to the patient’s health record where appropriate according to national data protection rules and with the patient’s consent; Engage in collaborative care, e.g. while assisting in detecting and managing chronic disease or bringing our expertise in medicines to specialised care networks; Ensure the continuity of pharmaceutical care during the patient’s transition between acute care settings and home; Build a community pharmacy research strategy to support the development of services; IMPROVE PUBLIC HEALTH Support safe and effective self-care and self-medication when providing health advice, responding to symptoms and/or offering services that promote healthy living and disease prevention; Improve adverse drug reactions reporting; Participate in the setting up and development of future or existing national eHealth systems Use our network better to spread public health messages and manage public health crises; Develop screening programmes and further contribute to immunisation strategies; Develop a pharmacy-based holistic public health service package and make it available to the community according to the local needs; CONTRIBUTE TO THE EFFICIENCY AND QUALITY OF THE HEALTH SYSTEM Deliver pharmacy services aiming to improve adherence and rationalise care of polymedicated patients; Continue to promote and facilitate greater use of cheaper medicines via appropriate substitution when suitable; Encourage services such as dispensing repeat prescriptions and monitoring pharmacotherapy of individual patients, recommending dosage adjustments when appropriate 

Recommendations Maintain consumers’ trust Continue efforts to improve information and advice Assist and support consumers for health decisions Dedicated courses on communication and consumer behavior as part of the Pharmacy degree Mandatory continued professional education to improve scientific knowledge but also communication skills Quality controls mechanisms Optimize the valuable role of pharmacists as an integral part of the health care system

The safety net

Thank you www.beuc.eu – health@beuc.eu